BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9345011)

  • 1. Functional correction of Fanconi anemia group A hematopoietic cells by retroviral gene transfer.
    Fu KL; Foe JR; Joenje H; Rao KW; Liu JM; Walsh CE
    Blood; 1997 Nov; 90(9):3296-303. PubMed ID: 9345011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
    Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM
    J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A functionally active retrovirus vector for gene therapy in Fanconi anemia group C.
    Walsh CE; Grompe M; Vanin E; Buchwald M; Young NS; Nienhuis AW; Liu JM
    Blood; 1994 Jul; 84(2):453-9. PubMed ID: 7517716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroviral mediated gene transfer of the Fanconi anemia complementation group C gene to hematopoietic progenitors of group C patients.
    Liu JM; Young NS; Walsh CE; Cottler-Fox M; Carter C; Dunbar C; Barrett AJ; Emmons R
    Hum Gene Ther; 1997 Sep; 8(14):1715-30. PubMed ID: 9322874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC).
    Liu JM; Kim S; Read EJ; Futaki M; Dokal I; Carter CS; Leitman SF; Pensiero M; Young NS; Walsh CE
    Hum Gene Ther; 1999 Sep; 10(14):2337-46. PubMed ID: 10515453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transduction of CD34-enriched human peripheral and umbilical cord blood progenitors using a retroviral vector with the Fanconi anemia group C gene.
    Walsh CE; Mann MM; Emmons RV; Wang S; Liu JM
    J Investig Med; 1995 Aug; 43(4):379-85. PubMed ID: 7552587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage.
    Carreau M; Gan OI; Liu L; Doedens M; McKerlie C; Dick JE; Buchwald M
    Blood; 1998 Apr; 91(8):2737-44. PubMed ID: 9531583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice.
    Río P; Segovia JC; Hanenberg H; Casado JA; Martínez J; Göttsche K; Cheng NC; Van de Vrugt HJ; Arwert F; Joenje H; Bueren JA
    Blood; 2002 Sep; 100(6):2032-9. PubMed ID: 12200363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtyping analysis of Fanconi anemia by immunoblotting and retroviral gene transfer.
    Pulsipher M; Kupfer GM; Naf D; Suliman A; Lee JS; Jakobs P; Grompe M; Joenje H; Sieff C; Guinan E; Mulligan R; D'Andrea AD
    Mol Med; 1998 Jul; 4(7):468-79. PubMed ID: 9713825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of mitomycin C sensitivity in Fanconi anemia complementation group C gene (Fac) knock-out mouse cells.
    Otsuki T; Wang J; Demuth I; Digweed M; Liu JM
    Int J Hematol; 1998 Apr; 67(3):243-8. PubMed ID: 9650445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel, membrane receptor-based retroviral vector for Fanconi anemia group C gene therapy.
    Machl AW; Planitzer S; Kubbies M
    Gene Ther; 1997 Apr; 4(4):339-45. PubMed ID: 9176520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of Fanconi anemia type C phenotypic abnormalities using a clinically suitable retroviral vector infection protocol.
    Freie BW; Dutt P; Clapp DW
    Cell Transplant; 1996; 5(3):385-93. PubMed ID: 8727007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Gene Therapy for Fanconi Anemia.
    Río P; Navarro S; Bueren JA
    Hum Gene Ther; 2018 Oct; 29(10):1114-1123. PubMed ID: 30117331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA.
    Lo Ten Foe JR; Rooimans MA; Bosnoyan-Collins L; Alon N; Wijker M; Parker L; Lightfoot J; Carreau M; Callen DF; Savoia A; Cheng NC; van Berkel CG; Strunk MH; Gille JJ; Pals G; Kruyt FA; Pronk JC; Arwert F; Buchwald M; Joenje H
    Nat Genet; 1996 Nov; 14(3):320-3. PubMed ID: 8896563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
    Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
    Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic correction of Fanconi anemia group C knockout mice.
    Gush KA; Fu KL; Grompe M; Walsh CE
    Blood; 2000 Jan; 95(2):700-4. PubMed ID: 10627482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic correction of Fanconi anemia cells in the murine bone marrow after carrier cell mediated delivery of lentiviral vector.
    Chakkaramakkil Verghese S; Goloviznina NA; Kurre P
    Stem Cell Res Ther; 2016 Nov; 7(1):170. PubMed ID: 27865213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroviral-mediated transduction of the fanconi anemia C complementing (FACC) gene in two murine transplantation models.
    Liu JM; Kim S; Walsh CE
    Blood Cells Mol Dis; 1995; 21(1):56-63. PubMed ID: 7544677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency.
    Verhoeyen E; Roman-Rodriguez FJ; Cosset FL; Levy C; Rio P
    Curr Gene Ther; 2017; 16(5):297-308. PubMed ID: 28067165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid lentiviral transduction preserves the engraftment potential of Fanca(-/-) hematopoietic stem cells.
    Müller LU; Milsom MD; Kim MO; Schambach A; Schuesler T; Williams DA
    Mol Ther; 2008 Jun; 16(6):1154-60. PubMed ID: 18398427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.